Henry Schein Stock News

M&T Bank Corp trimmed its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 7.0% during the 3rd quarter, Holdings Channel reports. The firm owned 11,236 shares of the companys stock after selling 845 shares during the quarter. M&T Bank Corps holdings in Henry Schein were worth $855,000 at the end of the most recent reporting period. []

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 9:45 a.m. ET.

Investors are optimistic about Henry Schein's (HSIC) better-than-expected third-quarter results and robust performances by its operating businesses.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 9:45 a.m. ET.

Sumitomo Mitsui Trust Holdings Inc. lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 12.9% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 415,553 shares of the companys stock after selling 61,760 shares during the period. Sumitomo Mitsui Trust Holdings Inc.s holdings in Henry Schein were worth $31,649,000 as of its most []

Henry Schein, Inc. (NASDAQ:HSIC) CEO Stanley M. Bergman sold 30,000 shares of the companys stock in a transaction on Tuesday, December 14th. The shares were sold at an average price of $75.43, for a total value of $2,262,900.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible []

Davy Global Fund Management Ltd lowered its position in Henry Schein, Inc. (NASDAQ:HSIC) by 31.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,625 shares of the companys stock after selling 8,921 shares during the quarter. Davy Global Fund Management Ltds []

Equities analysts expect Henry Schein, Inc. (NASDAQ:HSIC) to post $3.22 billion in sales for the current quarter, according to Zacks. Six analysts have provided estimates for Henry Scheins earnings, with the lowest sales estimate coming in at $3.09 billion and the highest estimate coming in at $3.34 billion. Henry Schein posted sales of $3.17 billion []

The OMNIA Partners cooperative contract is expected to expand Henry Schein's (HSIC) offerings in the field of Point-of-Care testing, personal protective equipment and essential medical supplies.

TCW Group Inc. trimmed its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 31.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,797 shares of the company’s stock after selling 7,190 shares during the period. TCW Group Inc.’s holdings in Henry Schein were […]

Key Companies in Orthodontics Market are Institut Straumann AG (Basel, Switzerland), Dentsply Sirona (Pennsylvania, U.S.), 3M (Minnesota, U.S.), Ormco Corporation (Brea, U.S.), DB Orthodontics (Silsden, U.K.), Henry Schein, Inc. (New York U.S.), Align Technology, Inc. (San Jose, U.S.), AMERICAN ORTHODONTICS (Wisconsin, U.S.), Great Lakes Dental Technologies (Tonawanda, U.S.) Key Companies in Orthodontics Market are Institut Straumann AG (Basel, Switzerland), Dentsply Sirona (Pennsylvania, U.S.), 3M (Minnesota, U.S.), Ormco Corporation (Brea, U.S.), DB Orthodontics (Silsden, U.K.), Henry Schein, Inc. (New York U.S.), Align Technology, Inc. (San Jose, U.S.), AMERICAN ORTHODONTICS (Wisconsin, U.S.), Great Lakes Dental Technologies (Tonawanda, U.S.)

Wall Street brokerages expect Henry Schein, Inc. (NASDAQ:HSIC) to post $0.92 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Six analysts have made estimates for Henry Scheins earnings, with estimates ranging from $0.88 to $1.05. Henry Schein reported earnings per share of $1.00 in the same quarter last year, which []